Prevalence of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 25 05 2022
accepted: 21 11 2022
revised: 01 10 2022
medline: 15 5 2023
pubmed: 7 12 2022
entrez: 6 12 2022
Statut: ppublish

Résumé

To identify the prevalence of non-bronchial systemic culprit arteries and their relationship to bleeding lobes in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization (BAE). Data of 83 consecutive patients with bronchiectasis and chronic pulmonary infection (non-tuberculous mycobacteriosis, aspergillosis, and tuberculosis) who underwent de novo BAE between January 2019 and December 2020 were retrospectively reviewed. The prevalence of culprit arteries was investigated. Fifty-five patients (66%) had 172 non-bronchial systemic culprit arteries. The bleeding lobes were the right upper, right middle, right lower, left upper, and left lower lobes in 14 (17%), 20 (24%), 7 (8%), 31 (37%), and 11 (13%) patients, respectively. The internal thoracic (49%; n = 41), intercostal (28%; n = 23), and inferior phrenic (28%; n = 23) arteries were the top three non-bronchial systemic culprit arteries, which were involved in all five types of bleeding lobes. The costocervical trunk and thoracoacromial and lateral thoracic arteries were predominant in patients with upper lobe bleeding. Ligament arteries were predominant in patients with left lower lobe bleeding. These findings will better ensure the identification of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection. All systemic arteries, especially those which are adjacent to the lung lesions, should be evaluated carefully using MDCT; the internal thoracic, intercostal, and inferior phrenic arteries should be proactively assessed using angiography. • Non-bronchial systemic culprit arteries were identified in 66% of patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization. • The internal thoracic (49%), intercostal (28%), and inferior phrenic (28%) arteries were the top three arteries, which were involved in all five types of bleeding lobes. • The costocervical trunk and thoracoacromial and lateral thoracic arteries were prominent in patients with upper lobe bleeding, and the ligament artery was prominent in patients with left lower lobe bleeding.

Identifiants

pubmed: 36472693
doi: 10.1007/s00330-022-09310-4
pii: 10.1007/s00330-022-09310-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4198-4204

Informations de copyright

© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Références

Panda A, Bhalla AS, Goyal A (2017) Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol 23:307–317
doi: 10.5152/dir.2017.16454 pubmed: 28703105 pmcid: 5508955
Marquis KM, Raptis CA, Rajput MZ et al (2021) CT for evaluation of hemoptysis. RadioGraphics 41:742–761
doi: 10.1148/rg.2021200150 pubmed: 33939537
Yoon W, Kim JK, Kim YH, Chung TW, Kang HK (2002) Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. RadioGraphics 22:1395–1409
doi: 10.1148/rg.226015180 pubmed: 12432111
Li PJ, Yu H, Wang Y et al (2019) Multidetector computed tomography angiography prior to bronchial artery embolization helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries and improve hemoptysis-free early survival rate in patients with hemoptysis. Eur Radiol 29:1950–1958
doi: 10.1007/s00330-018-5767-6 pubmed: 30324381
Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ (2005) Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology 234:292–298
doi: 10.1148/radiol.2341032079 pubmed: 15550375
Xu S, Guan LJ, Shi BQ, Tan YS, Zhang XJ (2020) Recurrent hemoptysis after bronchial artery embolization: prediction using a nomogram and artificial neural network model. AJR Am J Roentgenol 215:1490–1498
doi: 10.2214/AJR.20.22775 pubmed: 33052741
Yoon W, Kim YH, Kim JK, Kim YC, Park JG, Kang HK (2003) Massive hemoptysis: prediction of nonbronchial systemic arterial supply with chest CT. Radiology 227:232–238
doi: 10.1148/radiol.2271020324 pubmed: 12601194
Ishikawa H, Hara M, Ryuge M et al (2017) Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study. BMJ Open 7:e014805
doi: 10.1136/bmjopen-2016-014805 pubmed: 28213604 pmcid: 5318547
Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J (2006) Multi-detector row CT of hemoptysis. RadioGraphics 26:3–22
doi: 10.1148/rg.261045726 pubmed: 16418239
Remy J, Remy-Jardin M, Voisin C (1992) Endovascular management of bronchial bleeding. In: Butler J (ed) The bronchial circulation. Dekker, New York, pp 667–723
Woo S, Yoon CJ, Chung JW et al (2013) Bronchial artery embolization to control hemoptysis: comparison of N-butyl-2-cyanoacrylate and polyvinyl alcohol particles. Radiology 269:594–602
doi: 10.1148/radiol.13130046 pubmed: 23801773
Yoo DH, Yoon CJ, Kang SG, Burke CT, Lee JH, Lee CT (2011) Bronchial and nonbronchial systemic artery embolization in patients with major hemoptysis: safety and efficacy of N-butyl cyanoacrylate. AJR Am J Roentgenol 196:W199–W204
doi: 10.2214/AJR.10.4763 pubmed: 21257863
Zhang J, Zheng L, Zhao T, Huang S, Hu W (2020) A retrospective analysis of risk factors in recurrent hemoptysis patients with non-bronchial systematic artery feeding. Ann Transl Med 8:1593
doi: 10.21037/atm-20-5544 pubmed: 33437792 pmcid: 7791229
Jardin M, Remy J (1988) Control of hemoptysis: systemic angiography and anastomoses of the internal mammary artery. Radiology 168:377–383
doi: 10.1148/radiology.168.2.3393655 pubmed: 3393655
Hashimoto M, Heianna J, Okane K, Izumi J, Watarai J (1999) Internal mammary artery embolization for hemoptysis. Acta Radiol 40:187–190
doi: 10.3109/02841859909177736 pubmed: 10080732
Vujic I, Pyle R, Hungerford GD, Griffin CN (1982) Angiography and therapeutic blockade in the control of hemoptysis. The importance of nonbronchial systemic arteries. Radiology 143:19–23
doi: 10.1148/radiology.143.1.7063726 pubmed: 7063726
Cooper C, Moss AA, Buy JN, Stark DD (1983) CT appearance of the normal inferior pulmonary ligament. AJR Am J Roentgenol 141:237–240
doi: 10.2214/ajr.141.2.237 pubmed: 6603110
Takeda K, Kawashima M, Masuda K et al (2020) Long-term outcomes of bronchial artery embolization for patients with non-mycobacterial non-fungal infection bronchiectasis. Respiration 99:961–969
doi: 10.1159/000511132 pubmed: 33264771
Okuda K, Masuda K, Kawashima M et al (2016) Bronchial artery embolization to control hemoptysis in patients with Mycobacterium avium complex. Respir Investig 54:50–58
doi: 10.1016/j.resinv.2015.08.004 pubmed: 26718145
Ishikawa H, Ohbe H, Omachi N, Morita K, Yasunaga H (2021) Spinal cord infarction after bronchial artery embolization for hemoptysis: a nationwide observational study in Japan. Radiology 298:673–679
doi: 10.1148/radiol.2021202500 pubmed: 33464182
Kettenbach J, Ittrich H, Gaubert JY, Gebauer B, Vos JA (2022) CIRSE standards of practice on bronchial artery embolisation. Cardiovasc Interv Radiol 45:721–732
doi: 10.1007/s00270-022-03127-w
Ryuge M, Hara M, Hiroe T et al (2019) Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study. Eur Radiol 29:707–715
doi: 10.1007/s00330-018-5637-2 pubmed: 30054792

Auteurs

Takashi Nishihara (T)

Hemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, 2-8-10 Kamimatsu-cho, Kishiwada, City Osaka, 596-0827, Japan. takashinishihara1208@gmail.com.

Hideo Ishikawa (H)

Hemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, 2-8-10 Kamimatsu-cho, Kishiwada, City Osaka, 596-0827, Japan.

Naoki Omachi (N)

Hemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, 2-8-10 Kamimatsu-cho, Kishiwada, City Osaka, 596-0827, Japan.

Yu Yamaguchi (Y)

Hemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, 2-8-10 Kamimatsu-cho, Kishiwada, City Osaka, 596-0827, Japan.

Kazushi Kitaguchi (K)

Hemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, 2-8-10 Kamimatsu-cho, Kishiwada, City Osaka, 596-0827, Japan.

Tomoaki Hattori (T)

Hemoptysis and Pulmonary-Circulation Center, Eishinkai Kishiwada Rehabilitation Hospital, 2-8-10 Kamimatsu-cho, Kishiwada, City Osaka, 596-0827, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH